Jennifer, also known as, “Trie”, is an Associate Director in Medical Affairs for Jazz Pharmaceuticals, leading the Cannabinoid Science Education program. Trie has been working in the cannabinoid science space for nearly 7 years and was instrumental in building the content for CannabinoidClinical.com educational website and leads the Cannabinoid Education Working Group. Trie has presented to learners across the United States including scientific and healthcare providers, advocacy groups, medical societies, state government and policy making members, and beyond the US including the UN Commission on Narcotic Drugs. Prior to her current role, Trie was a Medical Science Liaison at Greenwich Biosciences, US subsidiary of GW Pharmaceuticals, providing scientific support to develop an FDA-approved cannabidiol therapy for the treatment of seizures associated with epilepsy. Trie received her Master of Science in Cellular and Molecular Biology from Saint Cloud State University and her PhD in Comparative and Molecular Biosciences at the University of Minnesota, School of Veterinary Medicine. Before graduate school, she spent several years working in academia performing laboratory research focused on neuroendocrinology.
The Least of Us About Sam Quinones Sam Quinones is a Los Angeles-based freelance journalist and author of four books of narrative nonfiction. His...
Does marijuana cause mental illness and violence? Alex Berenson published a doctorate type research in his book - Tell Your Children. Alex is also...
Healthy Minds relates to addiction and mental health, it is also an Emmy Award program. Dr. Borenstein shares his insights towards healthy minds. Jeffrey...